Objectives: Although antibiotic use in the community is a significant contributor to resistance, little is known about social patterns of use. This study aimed to explore the use of antibiotics by age, gender, ethnicity, socio-economic status and rurality.
Introduction
Antibiotic resistance is a major and growing problem worldwide. 1 -3 Consumption of antibiotics in the community (i.e. outside of hospital) contributes significantly to this problem. 4 Although there is evidence of high levels of antibiotic use, little is known about the social pattern of antibiotic use. For example, is usage higher amongst those of high or low socioeconomic status, and which gender and what age groups and ethnicities have high levels of antibiotic use? High consumption of antibiotics leads to increased antibiotic resistance, 5, 6 so understanding patterns of antibiotic use in the community is important. Identifying high users of antibiotics can help to identify groups amongst which resistance levels might be high and to develop and efficiently target strategies such as educational programmes to reduce antibiotic use.
A few studies have looked at variation in knowledge, expectations of being prescribed antibiotics or reported use of antibiotics amongst people by ethnic group, 7, 8 but we have found no population-based studies that report the extent of antibiotic use by ethnicity. While studies sometimes report results by educational level, 4 we have not found any about the use of antibiotics by socio-economic position. Studies show high levels of antibiotic prescribing for children, 9 but few have explored use by age and gender 10 and little is known about demographic 12 showed that people of lower socio-economic position had significantly higher consumption of antibiotics than those of higher position. This was true of both children and adults. Females received more prescriptions than males, and children more than adults.
The aim of this study was to investigate the extent of antibiotic use [the proportion of people who received an antibiotic prescription during a year and the level of use by defined daily doses (DDDs)] for people of differing age, gender, socioeconomic position, ethnicity and rurality.
In New Zealand patients pay a fee to see a family doctor and another fee per prescription item. For most people in the study region at the time of the research, the usual prescription fee was only a small amount ($NZ3, roughly 1.5 euros). Prescription medicines are provided free after the first 20 prescription items per year. It is possible to purchase private insurance to cover the cost of family doctor visits and prescriptions, though few people in New Zealand do this.
The study region, Te Tairawhiti, is the north eastern area of New Zealand's North Island. It occupies an area of 8355 km 2 (3% of New Zealand's total land size) and has a population of 44 499 people (1% of the national population). 13 Approximately three-quarters of Te Tairawhiti's population live in the main city of Gisborne. Te Tairawhiti is sparsely populated, with a population density of 5.6/km 2 compared with the national density of 16.1/km 2 . There are considerable differences in socio-economic position between M aori and non-M aori. Fifty-four percent of M aori and 24% of non-M aori live in the most deprived socio-economic areas, while 12% of M aori and 34% of non-M aori live in the least deprived socio-economic areas. 14 Accurate data on total consumption of antibiotics in New Zealand are not available because many antibiotic prescriptions are not funded, and therefore are not captured in the national dataset. 15 Attempts have been made to reduce prescribing. Since 1999, PHARMAC, the Pharmaceutical Management Agency, has run a campaign to educate the public about appropriate use of antibiotics and to improve general practitioners' prescribing. 16 Cultural and ethnic variation in knowledge and understanding of antibiotics has been found.
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Methods
The Te Tairawhiti region was chosen because of its population mix and geographical isolation. The region has high populations of the two biggest ethnic groups in New Zealand (47% indigenous M aori and 54% New Zealanders of European descent). The region has only one town with pharmacies (Gisborne). The whole region is considerably more than one hour's travel time from any other towns with pharmacies. We reasoned that inhabitants would be very unlikely to travel regularly to another town to pick up their prescription medicines, and that therefore by obtaining data from all the pharmacies in Gisborne we would be able to obtain a complete dataset of medicines use in the region.
Community pharmacies in New Zealand keep records of all prescriptions they dispense. These include patient data (e.g. name, address, date of birth), as well as details about the medicine dispensed (e.g. medicine name, dose, quantity). The main advantage of this data source is that all prescriptions are included, regardless of whether they received any government subsidy.
After ethics approval had been granted by the Northern Ethics Committee X (NTX/06/09/111), we visited all the pharmacies in Gisborne and downloaded electronic records of all 651190 dispensings from all eight community pharmacies and all 2939 dispensings to patients (other than inpatients) from the hospital pharmacy in Gisborne for the period 1 October 2005 to 30 September 2006 inclusive, in an encrypted form, onto USB keys. After removal of records not referring to identifiable individuals or for fees only (i.e. records where no medicine was dispensed), the dataset consisted of 619264 dispensing records.
People in New Zealand often collect medicines from more than one pharmacy. 18 Probabilistic matching methods, using an individual's full name, date of birth, gender and health identifier (if recorded), were used to identify records belonging to the same individual across pharmacies. The software package LinkPlus, 19 which employs an expectation maximization algorithm to assign match probabilities, 20 was used to perform and review the matching process. Matching yielded records for 38027 individuals with addresses locating them within the Te Tairawhiti region.
The Ministry of Health assigns healthcare users with a theoretically unique identifier for use in the health system. This healthcare identifier indexes a central repository of demographic information about healthcare users, which includes information on date of birth, gender and ethnicity. The individual's age and gender were obtained from the pharmacy records if they were present. Otherwise these were obtained from the central repository if possible (i.e. when a healthcare identifier was recorded for the individual or had been inferred through the matching process). Because pharmacies do not record ethnicity, this information was solely sourced from the central repository. Socio-economic position was determined using patient addresses and the NZDep index (New Zealand Index of Socioeconomic Deprivation). 21 NZDep has been well validated and is a commonly used measure of socio-economic deprivation in New Zealand. 22 -24 The methods for matching across pharmacies and to the central patient information repository are described in greater detail elsewhere. 25 Data were gathered on all medicines, but this paper focuses on antibiotics. We considered as antibiotics all medicines classified in the Anatomical Therapeutic Chemical (ATC) 26 system as J01: antibacterials for systemic use. Antimicrobials classified by other ATC codes, such as antivirals, antimycotics, antibiotics for external use and medicines used to eradicate Helicobacter pylori were excluded. DDDs/person/year were calculated as a metric of use, as recommended by the WHO Collaborating Centre for Drug Statistics Methodology (WHOCC). 26 This estimates the number of days, on average, that everyone (whether or not they took the medicine) in a defined population group is treated annually.
In the area studied, pharmacies sometimes dispense antibiotics (and other medicines) in bulk to prescribers, who then issue them to patients without an individual patient prescription [under a Medical Practitioner Supply Order (MPSO)]. The intention of MPSOs is to ensure that medicines can be provided in emergency situations. They are commonly used in rural areas in evenings, at weekends or at other times when it is not feasible for the patient to collect a prescription and they need to take medicines immediately. There is a list of specific medicines available on MPSO, but in the case of antibiotics this includes almost all the antibiotics that can normally be prescribed by general practitioners and funded without special permission. Our dataset included quantities of medicines dispensed to prescribers on MPSOs, but patient identifiers for the final recipients are not recorded, so we could not allocate these medicines to individuals. Instead we carried out a sensitivity analysis to investigate whether these bulk dispensings could have substantially changed our findings.
Population counts were obtained from the 2006 census, undertaken in the middle of the period for which we have data and therefore accurately reflecting the population during our study period. Prevalences Norris et al. 
Results
During the study year, 51% of the population (22 894 people) received a prescription for one or more antibiotics. b-Lactams and penicillins (J01C) were by far the most common group used (40% of the population received one or more prescription during the year) ( Table 1 ) and amoxicillin was the most commonly used medicine (20% of the population) ( Table 2) . On average people in the region received 9.25 DDDs in the study year. If bulk dispensings are included, 10.15 DDDs were dispensed/person. These measures of total consumption include children as well as adults, and DDDs are less accurate for children. People who received antibiotics during the study period received a median of 10.50 DDDs (interquartile range, 5.25-20.00).
Use was higher for females than for males (prevalence ratio, 1.18). The prevalence of people dispensed an antibiotic was higher for young people (under 25) and the elderly (75 and over), and lower for those in the middle age groups (Table 3 and Figure 1 ). The amount in DDDs/person/year broadly followed this pattern, except for those aged 15 and under (for whom DDDs are not appropriate since they rely on adult doses). However, even in the age group with the lowest use (35 -44 years), 41% of the population received at least one antibiotic prescription during the year, the average duration of treatment being 7.90 days. In the most elderly group (85 and over), 69% of people received an antibiotic and on average this treatment lasted 19.03 days.
The prevalence of antibiotic dispensings differed between males and females in all age groups except for children (0-15) and those aged 75-84.
Use was highest amongst people living in areas with middle or low levels of socio-economic deprivation (53% and 50% of the population receiving a prescription, respectively) and lowest amongst those living in areas with high levels of socio-economic deprivation (48% of the population received a prescription).
Forty-eight percent of M aori people and 55% of non-M aori received one or more antibiotic prescriptions during the study period. Fewer people in rural areas received a prescription than those living in urban areas. This was true for both M aori and non-M aori, but the difference was much larger for M aori than for non-M aori ( Figure 2 ). For children 6 years or under, the pattern was similar, with very low prevalence for rural M aori children (43%) compared with that for rural non-M aori (68%) or urban dwellers (80% and 85% for M aori and non-M aori, respectively). The pattern was also similar in terms of DDDs, although ethnic differences in urban areas were exacerbated. Bulk dispensings did not JAC substantially change this picture. Even if we made the extremely unlikely assumption that all of the antibiotics dispensed in bulk to rural practitioners were given to rural M aori and all of the urban bulk dispensings were given to urban M aori, the pattern of lower use for M aori, particular in rural areas, remained (Table 4) .
Discussion
More than half the population in our study area received a prescription for antibiotics in a 1 year period. Use was higher amongst females than males, and amongst children and the elderly. However, use was common even in middle adulthood. Rural M aori had very low rates of use compared with other groups. It should be noted that this study relied on dispensing data rather than use, and people may not take all the medicines The proportion of the population who received one or more antibiotic prescriptions in our study was extremely high compared with that found in other studies, which reported 30% -42%. 12, 27 However, the number of DDDs (roughly equivalent to days of treatment) was similar to that reported for a region in Denmark. 27 PHARMAC, New Zealand's pharmaceutical management agency, initiated a campaign to encourage the wise use of antibiotics in 2000 and, while success has been reported in reducing antibiotic use in children and in public expectations of receiving an antibiotic, 28 the results suggest that the prevalence of antibiotic use is still high. Other studies have also found higher rates of use amongst women. 27, 10 Patterns of antibiotic use by age and gender were similar to those found in England and Wales, 10 but rates at all age levels were much higher in our study. Rates of use in young people were high compared with other studies. 29, 30 Although increasing rates of use amongst those over 40 years old have been reported in another study, 27 rates did not rise as steeply or reach such high levels as in our study region. It is possible that some of the differences in rates for the elderly reported in different countries may be due to health system differences. For example, people in elderly care facilities may be classified as ambulatory patients in some jurisdictions (as in New Zealand) and hospital patients in others.
We found a different relationship between socio-economic position and antibiotic use from our pilot study, in which people of lower socio-economic position were more likely to receive antibiotic prescriptions. To our knowledge, no other population-based studies have looked at rates of antibiotic use by ethnicity. Other studies have found higher expectations for the use of antibiotics amongst minorities in the USA 8 and significant misunderstandings that may lead to high use 7 amongst immigrant groups in New Zealand. However, our study found that the prevalence of antibiotic use and the extent of use were much lower amongst M aori (particularly in rural areas) than amongst non-M aori. This is very concerning because M aori are one of the groups with the highest documented rate of acute rheumatic fever and rheumatic heart disease in the world 31 and Te Tairawhiti has the highest rate of hospital discharge with rheumatic fever in New Zealand. 32 In 2006, 62% of rheumatic fever cases in New Zealand were M aori and 89% were under 20 years of age. 33 Thus, New Zealand guidelines recommend a low threshold for suspicion of streptococcal infection in M aori children who present with sore throat and encourage prophylactic antibiotic treatment. 34 The low level of antibiotic use amongst young rural M aori children is particularly concerning. This may be the result of barriers to healthcare access. In particular, those living in rural areas without a car may face significant difficulties in accessing healthcare, 35 and Jatrana et al.
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found that M aori were more likely than non-M aori to report not picking up a prescription item in the previous year because of cost. As well as rheumatic fever, M aori experience high rates of other infectious diseases. 14 This study indicates that some areas in New Zealand may have very high levels of antibiotic prescribing and use. This emphasizes the need to reduce antibiotic prescribing in some groups in order to reduce the selective pressure towards antibiotic resistance. It suggests that, although prescribing for the elderly and children is high, it is also high for adults at all ages. The relationship between socio-economic position and antibiotic use needs to be explored further. Attention needs to be paid to barriers to access to healthcare, particularly for rural M aori, who may be missing out on simple interventions like antibiotic treatment for streptococcal pharyngitis, which may have significant long-term health benefits. Scenario 1, all MPSO DDDs are assumed to be dispensed to M aori. Scenario 2, 75% of MPSO DDDs are assumed to be dispensed to M aori, while the remaining 25% are assumed to be dispensed to non-M aori. Scenario 3, the split of MPSO DDDs is assumed to reflect the relative M aori and non-M aori populations.
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